191 related articles for article (PubMed ID: 38053512)
41. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zhang X; Zhou Y; Xu L; Han W; Chen H; Chen Y; Fu H; Zhou S; Zhao J; Wang Q; Feng F; Zhu X; Liu K; Huang X
Ann Hematol; 2015 May; 94(5):837-45. PubMed ID: 25512184
[TBL] [Abstract][Full Text] [Related]
42. Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
Youngster I; Eshel A; Geva M; Danylesko I; Henig I; Zuckerman T; Fried S; Yerushalmi R; Shem-Tov N; Fein JA; Bomze D; Shimoni A; Koren O; Shouval R; Nagler A
Bone Marrow Transplant; 2024 Mar; 59(3):409-416. PubMed ID: 38212672
[TBL] [Abstract][Full Text] [Related]
43. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
[TBL] [Abstract][Full Text] [Related]
44. [Clinical study of anti-human T cell porcine immunoglobulin with recombinant human tumor necrosis factor-α receptor II: IgG Fc in the treatment of 35 cases of grade III/IV acute graft-versus-host disease after allo-HSCT].
Liu DY; Yan S; Ma DD; Zhang C; Fu KB; Liu XM; Liu XH; Wang Y; Li XQ; Zhang JQ; Xiu YY; Peng XJ
Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):743-748. PubMed ID: 33113606
[No Abstract] [Full Text] [Related]
45. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.
Burgos da Silva M; Ponce DM; Dai A; M Devlin S; Gomes ALC; Moore G; Slingerland J; Shouval R; Armijo GK; DeWolf S; Fei T; Clurman A; Fontana E; Amoretti LA; Wright RJ; Andrlova H; Miltiadous O; Perales MA; Taur Y; Peled JU; van den Brink MRM
Blood; 2022 Dec; 140(22):2385-2397. PubMed ID: 35969834
[TBL] [Abstract][Full Text] [Related]
46. Human Amniotic Membrane-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease in an Intestinal Microbiome-Dependent Manner.
Bu X; Gao Y; Pan W; Liu L; Wang J; Yin Z; Ping B
Transplant Cell Ther; 2024 Feb; 30(2):189.e1-189.e13. PubMed ID: 37939900
[TBL] [Abstract][Full Text] [Related]
47. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
[TBL] [Abstract][Full Text] [Related]
48. Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Chen YB; Shah NN; Renteria AS; Cutler C; Jansson J; Akbari M; Chen C; Quadri S; Parfionovas A; Devine SM
Blood Adv; 2019 Dec; 3(23):4136-4146. PubMed ID: 31821456
[TBL] [Abstract][Full Text] [Related]
49. Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.
Zitzer NC; Garzon R; Ranganathan P
Front Immunol; 2018; 9():2561. PubMed ID: 30455702
[TBL] [Abstract][Full Text] [Related]
50. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
Parco S; Benericetti G; Vascotto F; Palmisciano G
Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
[TBL] [Abstract][Full Text] [Related]
51. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation].
Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475
[TBL] [Abstract][Full Text] [Related]
52. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
[TBL] [Abstract][Full Text] [Related]
53. Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease.
Zhou Z; Shang T; Li X; Zhu H; Qi YB; Zhao X; Chen X; Shi ZX; Pan G; Wang YF; Fan G; Gao X; Zhu Y; Feng Y
Front Physiol; 2020; 11():608279. PubMed ID: 33643058
[TBL] [Abstract][Full Text] [Related]
54. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.
Kakihana K; Fujioka Y; Suda W; Najima Y; Kuwata G; Sasajima S; Mimura I; Morita H; Sugiyama D; Nishikawa H; Hattori M; Hino Y; Ikegawa S; Yamamoto K; Toya T; Doki N; Koizumi K; Honda K; Ohashi K
Blood; 2016 Oct; 128(16):2083-2088. PubMed ID: 27461930
[TBL] [Abstract][Full Text] [Related]
55. Impact of anti-anaerobic antibiotic activity on graft-versus-host disease in allogeneic hematopoietic stem cell transplant (HSCT) recipients at an institution that utilizes antibiotic cycling.
Hanks CR; Slain D; Kanate AS; Wen S; Cumpston A
Transpl Infect Dis; 2021 Aug; 23(4):e13676. PubMed ID: 34165853
[TBL] [Abstract][Full Text] [Related]
56. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
57. Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.
Fowler DH; Foley J; Whit-Shan Hou J; Odom J; Castro K; Steinberg SM; Gea-Banacloche J; Kasten-Sportes C; Gress RE; Bishop MR
Clin Gastroenterol Hepatol; 2004 Mar; 2(3):237-45. PubMed ID: 15017608
[TBL] [Abstract][Full Text] [Related]
58. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
[TBL] [Abstract][Full Text] [Related]
59. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.
Ranganathan P; Ngankeu A; Zitzer NC; Leoncini P; Yu X; Casadei L; Challagundla K; Reichenbach DK; Garman S; Ruppert AS; Volinia S; Hofstetter J; Efebera YA; Devine SM; Blazar BR; Fabbri M; Garzon R
J Immunol; 2017 Mar; 198(6):2500-2512. PubMed ID: 28159900
[TBL] [Abstract][Full Text] [Related]
60. Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study.
Liu YC; Gau JP; Lin PY; Liu CJ; Liu CJ; Liu JH; Fan NW
PLoS One; 2016; 11(11):e0167129. PubMed ID: 27902756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
